Latest Insider Transactions at Steris PLC (STE)
This section provides a real-time view of insider transactions for Steris PLC (STE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STERIS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STERIS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+30.06%
|
$2,464,000
$77.07 P/Share
|
|
May 15
2024
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
2,000
-73.94%
|
$474,000
$237.65 P/Share
|
|
May 15
2024
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+42.51%
|
$172,000
$86.23 P/Share
|
|
May 14
2024
|
Karen L Burton VP & CAO |
SELL
Open market or private sale
|
Direct |
3,000
-44.39%
|
$705,000
$235.95 P/Share
|
|
May 14
2024
|
Mohsen Sohi Director |
SELL
Open market or private sale
|
Direct |
2,037
-4.25%
|
$474,621
$233.5 P/Share
|
|
May 14
2024
|
Mohsen Sohi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,037
+7.71%
|
$103,887
$51.53 P/Share
|
|
May 13
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
2,024
-15.11%
|
$469,568
$232.13 P/Share
|
|
May 13
2024
|
Jacqueline B Kosecoff Director |
SELL
Open market or private sale
|
Direct |
4,584
-100.0%
|
$1,058,904
$231.53 P/Share
|
|
May 13
2024
|
Jacqueline B Kosecoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584
+50.0%
|
$233,784
$51.53 P/Share
|
|
Dec 04
2023
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-1.49%
|
$19,502
$199.27 P/Share
|
|
Dec 04
2023
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
333
+4.82%
|
-
|
|
Oct 09
2023
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-2.78%
|
$40,050
$225.81 P/Share
|
|
Oct 09
2023
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
605
+8.62%
|
-
|
|
Oct 02
2023
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-1.44%
|
$18,275
$215.5 P/Share
|
|
Oct 02
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.28%
|
$27,950
$215.5 P/Share
|
|
Oct 02
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-1.96%
|
$36,765
$215.5 P/Share
|
|
Oct 02
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
61
-0.2%
|
$13,115
$215.5 P/Share
|
|
Oct 02
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-0.38%
|
$5,590
$215.5 P/Share
|
|
Jun 02
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-1.61%
|
$102,090
$205.47 P/Share
|
|
Jun 02
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-2.75%
|
$50,635
$205.47 P/Share
|
|
Jun 02
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,422
-4.89%
|
$496,510
$205.47 P/Share
|
|
Jun 02
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-1.84%
|
$26,035
$205.47 P/Share
|
|
Jun 02
2023
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
103
-1.72%
|
$21,115
$205.47 P/Share
|
|
Jun 01
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,491
-2.92%
|
$301,182
$202.42 P/Share
|
|
Jun 01
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-0.48%
|
$8,686
$202.42 P/Share
|
|
Jun 01
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
60
-0.86%
|
$12,120
$202.42 P/Share
|
|
Jun 01
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.72%
|
$45,450
$202.42 P/Share
|
|
Jun 01
2023
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-2.47%
|
$47,672
$202.42 P/Share
|
|
May 31
2023
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,879
+8.37%
|
-
|
|
May 31
2023
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
830
-2.11%
|
$165,170
$199.97 P/Share
|
|
May 31
2023
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
2,697
+16.76%
|
-
|
|
May 31
2023
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-5.72%
|
$129,151
$199.97 P/Share
|
|
May 31
2023
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,924
+20.21%
|
-
|
|
May 31
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-3.8%
|
$299,694
$199.97 P/Share
|
|
May 31
2023
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
723
+9.77%
|
-
|
|
May 31
2023
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
175
-2.86%
|
$34,825
$199.97 P/Share
|
|
May 31
2023
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
1,278
+17.57%
|
-
|
|
May 31
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+16.14%
|
-
|
|
May 31
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.44%
|
$6,368
$199.97 P/Share
|
|
May 31
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
3,471
+10.05%
|
-
|
|
May 31
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-0.89%
|
$49,551
$199.97 P/Share
|
|
May 31
2023
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,313
+19.47%
|
-
|
|
May 31
2023
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,020
+12.76%
|
-
|
|
May 31
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-1.26%
|
$15,124
$199.97 P/Share
|
|
May 16
2023
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
2,058
-48.85%
|
$430,122
$209.11 P/Share
|
|
May 16
2023
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,058
+42.69%
|
$176,988
$86.23 P/Share
|
|
May 16
2023
|
Richard C Breeden Director |
SELL
Open market or private sale
|
Direct |
12,130
-30.25%
|
$2,523,040
$208.61 P/Share
|
|
May 15
2023
|
Richard C Breeden Director |
SELL
Open market or private sale
|
Direct |
2,737
-6.39%
|
$577,507
$211.0 P/Share
|
|
May 15
2023
|
Jacqueline B Kosecoff Director |
SELL
Open market or private sale
|
Direct |
4,657
-100.0%
|
$987,284
$212.56 P/Share
|
|
May 15
2023
|
Jacqueline B Kosecoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,657
+50.0%
|
$200,251
$43.92 P/Share
|